Clinical Trials List
2012-01-05 - 2013-06-30
Phase III
Terminated4
ICD-10F25.9
Schizoaffective disorder, unspecified
ICD-9295.73
Schizo-affective type, subchronic with acute exacerbation
A phase 3, multicenter, randomized, double-blind, placebo-controlled Trial of Fixed-dose OPC-34712 (4,2, and 1 mg/day) in the Treatment of Adults With Acute Schizophrenia
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
IQVIA Solutions Taiwan Ltd.
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
17 Terminated
Co-Principal Investigator
- 林式穀 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蔡冠逸 Division of Psychiatry
- 林世祺 Division of Psychiatry
- 林世祺醫師 Division of Psychiatry
- 郭兆展 Division of Psychiatry
- mei feng Huang Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
660 participants
